These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 15330323)

  • 1. Susceptibility patterns in Pseudomonas aeruginosa causing nosocomial infections.
    Astal Z
    J Chemother; 2004 Jun; 16(3):264-8. PubMed ID: 15330323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a program to reduce hospital ciprofloxacin use on nosocomial Pseudomonas aeruginosa susceptibility to quinolones and other antimicrobial agents.
    Cook PP; Das TD; Gooch M; Catrou PG
    Infect Control Hosp Epidemiol; 2008 Aug; 29(8):716-22. PubMed ID: 18590455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial resistance profiles and associated factors of Acinetobacter and Pseudomonas aeruginosa nosocomial infection among patients admitted at Dessie comprehensive specialized Hospital, North-East Ethiopia. A cross-sectional study.
    Mekonnen H; Seid A; Molla Fenta G; Gebrecherkos T
    PLoS One; 2021; 16(11):e0257272. PubMed ID: 34780494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Report: prevalence and resistance pattern of Pseudomonas aeruginosa against various antibiotics.
    Khan JA; Iqbal Z; Rahman SU; Farzana K; Khan A
    Pak J Pharm Sci; 2008 Jul; 21(3):311-5. PubMed ID: 18614431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo development of antimicrobial resistance in Pseudomonas aeruginosa strains isolated from the lower respiratory tract of Intensive Care Unit patients with nosocomial pneumonia and receiving antipseudomonal therapy.
    Riou M; Carbonnelle S; Avrain L; Mesaros N; Pirnay JP; Bilocq F; De Vos D; Simon A; Piérard D; Jacobs F; Dediste A; Tulkens PM; Van Bambeke F; Glupczynski Y
    Int J Antimicrob Agents; 2010 Dec; 36(6):513-22. PubMed ID: 20926262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multi-drug resistance of blood stream, urinary tract and surgical site nosocomial infections of Acinetobacter baumannii and Pseudomonas aeruginosa among patients hospitalized at Felegehiwot referral hospital, Northwest Ethiopia: a cross-sectional study.
    Motbainor H; Bereded F; Mulu W
    BMC Infect Dis; 2020 Jan; 20(1):92. PubMed ID: 32000693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of resistance, cross-resistance and antimicrobial combinations for Pseudomonas aeruginosa isolates from 1997 to 2009.
    Master RN; Clark RB; Karlowsky JA; Ramirez J; Bordon JM
    Int J Antimicrob Agents; 2011 Oct; 38(4):291-5. PubMed ID: 21737249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Four years of monitoring of antibiotic sensitivity rates of Pseudomonas aeruginosa and Acinetobacter baumannii strains isolated from patients in intensive care unit and inpatient clinics].
    Alişkan H; Colakoğlu S; Turunç T; Demiroğlu YZ; Erdoğan F; Akin S; Arslan H
    Mikrobiyol Bul; 2008 Apr; 42(2):321-9. PubMed ID: 18697430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-drug resistant pseudomonas aeruginosa: a threat of nosocomial infections in tertiary care hospitals.
    Ali Z; Mumtaz N; Naz SA; Jabeen N; Shafique M
    J Pak Med Assoc; 2015 Jan; 65(1):12-6. PubMed ID: 25831667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multidrug resistance in Pseudomonas aeruginosa isolated from nosocomial respiratory and urinary infections in Aleppo, Syria.
    Mahfoud M; Al Najjar M; Hamzeh AR
    J Infect Dev Ctries; 2015 Feb; 9(2):210-3. PubMed ID: 25699497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efflux pump genes and antimicrobial resistance of Pseudomonas aeruginosa strains isolated from lower respiratory tract infections acquired in an intensive care unit.
    Ozer B; Duran N; Onlen Y; Savas L
    J Antibiot (Tokyo); 2012 Jan; 65(1):9-13. PubMed ID: 22086166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotic susceptibility patterns of Pseudomonas aeruginosa to available antipseudomonal drugs in Ibadan, Nigeria.
    Ogbolu DO; Ogunledun A; Adebiyi OE; Daini OA; Alli AO
    Afr J Med Med Sci; 2008 Dec; 37(4):339-44. PubMed ID: 19301711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The peculiarities of Pseudomonas aeruginosa resistance to antibiotics and prevalence of serogroups.
    Gailiene G; Pavilonis A; Kareiviene V
    Medicina (Kaunas); 2007; 43(1):36-42. PubMed ID: 17297282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Susceptibility patterns of Pseudomonas aeruginosa strains isolated in the Monastir region, Tunisia].
    Abdallah HB; Noomen S; Khélifa AB; Sahnoun O; Elargoubi A; Mastouri M
    Med Mal Infect; 2008 Oct; 38(10):554-6. PubMed ID: 18814981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Previous Antibiotic Exposure and Antimicrobial Resistance Patterns of
    Djordjevic ZM; Folic MM; Jankovic SM
    Balkan Med J; 2017 Dec; 34(6):527-533. PubMed ID: 29215335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial susceptibilities and clinical characterization of Pseudomonas aeruginosa isolates from urinary tract infections.
    Zhang X; Niu S; Zhang L
    Urol Int; 2014; 93(4):464-9. PubMed ID: 24642393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial susceptibility patterns in Pseudomonas aeruginosa: data from a multicenter Intensive Care Unit Surveillance Study (ISS) in the United States.
    Friedland I; Gallagher G; King T; Woods GL
    J Chemother; 2004 Oct; 16(5):437-41. PubMed ID: 15565908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical, microbiologic, and epidemiologic characteristics of Pseudomonas aeruginosa infections in a University Hospital, Malatya, Turkey.
    Yetkin G; Otlu B; Cicek A; Kuzucu C; Durmaz R
    Am J Infect Control; 2006 May; 34(4):188-92. PubMed ID: 16679175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pseudomonas aeruginosa: Evaluation of Pathogen Burden and Drug-Resistance Trends in a Tertiary Care Hospital.
    Saeed M; Rasheed F; Afzal RK; Hussain S; Riaz S; Ahmad A
    J Coll Physicians Surg Pak; 2018 Apr; 28(4):279-283. PubMed ID: 29615167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial susceptibility of pathogens isolated from patients with complicated intra-abdominal infections at five medical centers in Taiwan that continuously participated in the Study for Monitoring Antimicrobial Resistance Trends (SMART) from 2006 to 2010.
    Lee YL; Chen YS; Toh HS; Huang CC; Liu YM; Ho CM; Lu PL; Ko WC; Chen YH; Wang JH; Tang HJ; Yu KW; Liu YC; Chuang YC; Liu CE; Hsueh PR
    Int J Antimicrob Agents; 2012 Jun; 40 Suppl():S29-36. PubMed ID: 22749056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.